ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment

Wang, Fang; Tao, Zhennan; Tian, Zhen; Jin, Jiaqi; Dong, Jiawei; Dai, Yuxiang; Yu, Wanli*; Tang, Bin*; Hu, Shaoshan*华中科技大学; 南昌大学; 南京大学; 哈尔滨医科大学
Frontiers in Genetics2022-7-5DOI: 10.3389/fgene.2022.874896
2被引2阅读
引用收藏
分享

摘要

Background: Lower-grade gliomas (LGGs) carry a high risk of malignant transformation, leading to severe neurologic deterioration and ultimately, death. The tumor microenvironment (TME) plays an essential role in tumor maintenance, progression, and immunotherapy resistance. Therefore, the LGG TME deserves comprehensive exploration for a novel therapeutic target.Methods: The ESTIMATE algorithm was used to estimate infiltrating stromal and immune cells of LGG patients obtained from the Cancer Genome Atlas (TCGA) database. Kaplan-Meier analysis was performed to classify survival differences. TME-related differentially expressed genes were identified between the low- and high-immune/stromal groups. Hub genes were screened by constructing protein-protein interaction networks and performing the Cox regression analysis. Differential analysis, survival analysis, gene set enrichment analysis, and clinical relevance analysis specific to hub genes were evaluated by using the TCGA and the Chinese Glioma Genome Atlas datasets, and the results were validated by qRT-PCR, Western blotting, and immunohistochemistry in tissues from LGG patients.Results: The immune and stromal components in TME were negatively related to patient prognosis. Differentially expressed genes sharing immune score and stromal score were mainly involved in the immune response. C-C chemokine receptor type 5 (CCR5), as only a hub gene, was significantly higher in LGG patients than normal patients and negatively correlated with the prognosis of patients. High-expression CCR5 was positively related to immune-related and tumor progression pathways. CCR5 protein expression was higher in LGG with isocitrate dehydrogenase wildtype. Validated results showed that CCR5 was upregulated in LGG tissues at mRNA and protein levels and could affect immune cell infiltration. These results suggested that CCR5 was a potential indicator for the status of TME.Conclusion: Glioma cells remodel the immune microenvironment through the high expression of CCR5 and lead to a poor prognosis in patients with LGG. The inhibition of CCR5 may contribute to the efficacy of LGG immunotherapy.

学科与关键词

关键词
tumor microenvironmentLGGgliomaCCR5immunological biomarker
相关
加载中…
  • ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy
    Cheng, Xingbo; Liu, Zhendong; Liang, Wenjia; Zhu, Qingyun; Wang, Chao; Wang, Hongbo; Zhang, Jiangfen; Li, Pengxu; Gao, Yanzheng*International Journal of Biochemistry and Cell Biology, 2023, 158: 106409.被引 3
  • Identification of COL1A1 associated with immune infiltration in brain lower grade glioma
    Ren, Junyu; Da, Junlong; Hu, Narisu*PLoS One, 2022, 17(7).被引 3
  • A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma
    Li, Xiangpan; Xiong, Kewei*; Bi, Dong; Zhao, Chen*Frontiers in Genetics, 2022, 13: 839884.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-07-05
卷期
第 13 卷
页码
874896
DOI
10.3389/fgene.2022.874896
期刊等级
3区
成果收录
SCIE

作者

  • W

    Wang, Fang (第一作者)

    harbin med univ · zhejiang prov peoples hosp

  • T

    Tao, Zhennan

    nanjing univ

查看全部 9 位作者收起作者
  • T

    Tian, Zhen

    huazhong univ sci & technol · hubei canc hosp

  • J

    Jin, Jiaqi

    harbin med univ · zhejiang prov peoples hosp

  • D

    Dong, Jiawei

    harbin med univ · zhejiang prov peoples hosp

  • D

    Dai, Yuxiang

    nanjing univ

  • Y

    Yu, Wanli (通讯)

    nanchang univ

  • T

    Tang, Bin (通讯)

    nanchang univ

  • H

    Hu, Shaoshan (通讯)

    harbin med univ · zhejiang prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417